Evidence map›Paper›PMID 33525334›Full record

ReviewInternational journal of molecular sciences2021

Neurometals in the Pathogenesis of Prion Diseases.

Masahiro Kawahara, Midori Kato-Negishi, Ken-Ichiro Tanaka

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Crosstalk of copper and zinc in the pathogenesis of vascular dementia.Journal of clinical biochemistry and nutrition · 2022
    Article
  9. What is the role of lipids in prion conversion and disease?Frontiers in molecular neuroscience · 2022
    Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Masahiro KawaharaDepartment of Bio-Analytical Chemistry, Research Institute of Pharmaceutical Sciences, Faculty of Pharmacy, Musashino University, Tokyo 202-8585, Japan.ORCID 0000-0002-3334-4235
Midori Kato-NegishiDepartment of Bio-Analytical Chemistry, Research Institute of Pharmaceutical Sciences, Faculty of Pharmacy, Musashino University, Tokyo 202-8585, Japan.
Ken-Ichiro TanakaDepartment of Bio-Analytical Chemistry, Research Institute of Pharmaceutical Sciences, Faculty of Pharmacy, Musashino University, Tokyo 202-8585, Japan.
Musashino University · JP

Funding

Grant-in Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan JP26460177 and JP17H03197
6 · The paper itself

Abstract

Prion diseases are progressive and transmissive neurodegenerative diseases. The conformational conversion of normal cellular prion protein (PrP

Indexed as

Alzheimer DiseaseAnimalsBrainCations, DivalentCopperHomeostasisHumansIronManganeseNeuronsPrion DiseasesProtein BindingPrPC ProteinsPrPSc ProteinsSynapsesSynaptic TransmissionCations, DivalentCopperIronManganesePrPC ProteinsPrPSc ProteinsZincAlzheimer’s diseaseamyloidcalcium homeostasisdementia with Lewy bodiesneurotoxicitysynapse

Identifiers

PMID33525334
PMCPMC7866166
OpenAlexW3126060668

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.